Dominant and reactive archetypes of immunity in tumors
Toulouse
(Haute-Garonne) •
Mardi 4 mai 2021, 16h00
Selected publications
Hu KH, Eichorst JP, McGinnis CS, Patterson DM, Chow ED, Kersten K, Jameson SC, Gartner ZJ, Rao AA, Krummel MF. ZipSeq: barcoding for real-time mapping of single cell transcriptomes. 2020 Nat Methods doi:10.1038/s41592-020-0880-2
Mujal AM, Krummel MF. Immunity as a continuum of archetypes. 2019 Science 364(6435):28-29
Binnewies M, Mujal AM, Pollack JL, Combes AJ, Hardison EA, Barry KC, Tsui J, Ruhland MK, Kersten K, Abushawish MA, Spasic M, Giurintano JP, Chan V, Daud AI, Ha P, Ye CJ, Roberts EW, Krummel MF. Unleashing type-2 dendritic cells to drive protective antitumor CD4+ T cell immunity. 2019 Cell 177(3):556-571.e16
Barry K., Hsu J., Broz M., Cueto F., Binnewies M., Combes A., Nelson A., Loo K., Kumar R., Rosenblum M., Alvarado M., Wolf D., Bogunovic D., Bhardwaj N., Daud A., Ha P., Ryan W., Pollack J., Samad B., Asthana S., Chan V., Krummel M.F. A Natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments. 2018 Nat Med doi: 10.1038/s41591-018-0085-8